Home Article ResMed CEO sells 3,200 shares

ResMed CEO sells 3,200 shares

ResMed CEO sells 3,200 shares

Also Noted

Default Author Head Shot

By HME News Staff

Updated Thu June 19, 2014

NEW YORK - ResMed CEO Michael Farrell sold 3,200 shares of company stock on the open market June 16. Farrell sold the shares at an average price of $53.20 for a total of $170,240. He now directly owns 106,655 shares valued at approximately $5.7 million. On Wednesday, June 18, ResMed traded up 0.70% at $53.06, reports say. Farrell is one of a number of execs at the company who has sold shares in May and June.

Comments

To comment on this post, please log in to your account or set up an account now.